Clinical and laboratory profile of juvenile-onset systemic sclerosis in a Brazilian cohort.
Systemic sclerosis
age at onset
epidemiology
Journal
Journal of scleroderma and related disorders
ISSN: 2397-1991
Titre abrégé: J Scleroderma Relat Disord
Pays: England
ID NLM: 101685427
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
21
12
2017
accepted:
18
03
2018
entrez:
6
4
2022
pubmed:
1
2
2019
medline:
1
2
2019
Statut:
ppublish
Résumé
To characterize the clinical and laboratory profile of juvenile-onset compared to adult-onset systemic sclerosis in a large Brazilian cohort. Retrospective analysis of a cohort of 1016 systemic sclerosis patients followed at the Scleroderma Outpatient Clinic from two referral university centers in Brazil. Patients were classified as systemic sclerosis according to the 1980 American College of Rhaumatology (ACR) criteria. Juvenile-onset systemic sclerosis was defined if age at onset was <16 years. Thirty-one (3.1%) patients were classified as juvenile-onset systemic sclerosis. These patients were predominantly females (90.3%), Caucasians (71.0%), and presented diffuse systemic sclerosis (51.6%), with mean age at onset of 12.71 years. Compared to the adult-onset patients, juvenile onset was associated with diffuse systemic sclerosis (p < 0.001), calcinosis (p < 0.001), myositis (p = 0.050), and lower frequency of interstitial lung disease (p = 0.050), pulmonary hypertension (p = 0.035), and esophageal (p = 0.005) involvement. Juvenile-onset systemic sclerosis characterized a distinct clinical pattern in this large series of systemic sclerosis patients, since it was predominantly associated with diffuse systemic sclerosis without significant organ involvement.
Identifiants
pubmed: 35382153
doi: 10.1177/2397198318769796
pii: 10.1177_2397198318769796
pmc: PMC8922581
doi:
Types de publication
Journal Article
Langues
eng
Pagination
43-48Informations de copyright
© The Author(s) 2018.
Déclaration de conflit d'intérêts
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
J Scleroderma Relat Disord. 2016 May-Aug;1(2):177-240
pubmed: 29242839
J Rheumatol. 2005 Oct;32(10):1992-2001
pubmed: 16206357
J Rheumatol. 1988 Feb;15(2):202-5
pubmed: 3361530
Mod Rheumatol. 2013 Jul;23(4):759-64
pubmed: 22903259
Clin Rev Allergy Immunol. 2019 Jun;56(3):293-307
pubmed: 28849549
Rheumatology (Oxford). 2009 Feb;48(2):96-7
pubmed: 19028745
Curr Rheumatol Rep. 2015 Mar;17(3):18
pubmed: 25761925
Clin Rheumatol. 2007 Aug;26(8):1259-62
pubmed: 17180299
Rheumatology (Oxford). 2009 Feb;48(2):119-22
pubmed: 18854345
Rheumatology (Oxford). 2012 Oct;51(10):1832-7
pubmed: 22728264
Autoimmun Rev. 2010 Mar;9(5):A311-8
pubmed: 19906362
J Rheumatol. 2006 May;33(5):1004-13
pubmed: 16583463
Arthritis Rheum. 2006 Dec;54(12):3971-8
pubmed: 17133611
Arthritis Rheum. 2012 Dec;64(12):4143-50
pubmed: 22886849
J Rheumatol. 2012 Oct;39(10):1971-8
pubmed: 22896025
Arthritis Rheum. 1980 May;23(5):581-90
pubmed: 7378088
Microvasc Res. 2015 Nov;102:19-24
pubmed: 26254260
Pediatr Rheumatol Online J. 2007 May 01;5:6
pubmed: 17550632
PLoS One. 2011 Mar 09;6(3):e17551
pubmed: 21408076
Arthritis Rheum. 2007 Mar 15;57(2):203-12
pubmed: 17330294
Semin Arthritis Rheum. 2008 Feb;37(4):223-35
pubmed: 17692364
J Rheumatol. 2010 Nov;37(11):2422-6
pubmed: 20843905
Rheumatology (Oxford). 2000 May;39(5):556-9
pubmed: 10852989
Rheum Dis Clin North Am. 2008 Feb;34(1):239-55; ix
pubmed: 18329543